Eagle Asset Management Inc Novo Nordisk A S Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Eagle Asset Management Inc holds 17,893 shares of NVO stock, worth $1.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,893
Previous 16,213 10.36%
Holding current value
$1.53 Million
Previous $2.31 Million 7.95%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$119.07 - $145.42 $200,037 - $244,305
1,680 Added 10.36%
17,893 $2.13 Million
Q2 2024

Aug 12, 2024
SELL
$122.71 - $146.91 $64,300 - $76,980
-524 Reduced 3.13%
16,213 $2.31 Million
Q1 2024

May 09, 2024
SELL
$102.11 - $135.92 $52,790 - $70,270
-517 Reduced 3.0%
16,737 $2.15 Million
Q4 2023

Feb 12, 2024
SELL
$87.78 - $105.45 $81,196 - $97,541
-925 Reduced 5.09%
17,254 $1.78 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $803,182 - $1.76 Million
8,832 Added 94.49%
18,179 $1.65 Million
Q2 2023

Aug 09, 2023
SELL
$155.98 - $172.65 $53,033 - $58,701
-340 Reduced 3.51%
9,347 $1.51 Million
Q1 2023

May 08, 2023
SELL
$132.34 - $159.14 $25,276 - $30,395
-191 Reduced 1.93%
9,687 $1.54 Million
Q4 2022

Feb 14, 2023
SELL
$102.55 - $135.33 $22,150 - $29,231
-216 Reduced 2.14%
9,878 $1.34 Million
Q3 2022

Nov 07, 2022
BUY
$95.28 - $116.93 $127,008 - $155,867
1,333 Added 15.22%
10,094 $1.01 Million
Q2 2022

Aug 10, 2022
BUY
$103.24 - $121.81 $292,582 - $345,209
2,834 Added 47.82%
8,761 $976,000
Q1 2022

May 12, 2022
SELL
$93.1 - $112.54 $367,000 - $443,632
-3,942 Reduced 39.94%
5,927 $658,000
Q4 2021

Feb 11, 2022
BUY
$95.88 - $117.08 $21,189 - $25,874
221 Added 2.29%
9,869 $1.1 Million
Q3 2021

Nov 10, 2021
BUY
$84.42 - $106.62 $232,155 - $293,205
2,750 Added 39.87%
9,648 $926,000
Q2 2021

Aug 11, 2021
BUY
$67.66 - $84.76 $25,913 - $32,463
383 Added 5.88%
6,898 $577,000
Q1 2021

May 14, 2021
BUY
$67.06 - $75.82 $192,596 - $217,755
2,872 Added 78.84%
6,515 $440,000
Q4 2020

Feb 12, 2021
SELL
$63.89 - $73.8 $686,945 - $793,497
-10,752 Reduced 74.69%
3,643 $254,000
Q3 2020

Nov 12, 2020
SELL
$63.69 - $70.22 $40,761 - $44,940
-640 Reduced 4.26%
14,395 $1.01 Million
Q2 2020

Aug 12, 2020
SELL
$58.54 - $67.94 $9,190 - $10,666
-157 Reduced 1.03%
15,035 $985,000
Q1 2020

May 11, 2020
SELL
$49.46 - $64.78 $34,671 - $45,410
-701 Reduced 4.41%
15,192 $914,000
Q4 2019

Feb 07, 2020
SELL
$49.86 - $58.26 $83,216 - $97,235
-1,669 Reduced 9.5%
15,893 $919,000
Q3 2019

Nov 04, 2019
BUY
$47.54 - $53.43 $834,897 - $938,337
17,562 New
17,562 $907,000

Others Institutions Holding NVO

# of Institutions
1,870
Shares Held
317M
Call Options Held
5.49M
Put Options Held
7.77M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $194B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email